IAM
Innovis Asset Management Portfolio holdings
AUM
$260M
This Quarter Return
+9.26%
1 Year Return
+28.13%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$221M
AUM Growth
–
Cap. Flow
+$221M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
36.58%
Holding
150
New
150
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$15.7M |
| 2 |
UnitedHealth
UNH
|
$9.29M |
| 3 |
HES
Hess
HES
|
$8.19M |
| 4 |
Pfizer
PFE
|
$7.93M |
| 5 |
Intuitive Surgical
ISRG
|
$6.94M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 27.74% |
| 2 | Healthcare | 24.27% |
| 3 | Financials | 11.21% |
| 4 | Energy | 10.63% |
| 5 | Consumer Discretionary | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Aurinia Pharmaceuticals
AUPH
$1.58B
| $247K | 0.11% |
+57,263
| New | +$247K |
|
127
Fortinet
FTNT
$60.4B
| $238K | 0.11% |
+4,875
| New | +$238K |
|
128
Vanguard High Dividend Yield ETF
VYM
$64B
| $237K | 0.11% |
+2,194
| New | +$237K |
|
129
Evolv Technologies
EVLV
$1.42B
| $227K | 0.1% |
+87,818
| New | +$227K |
|
130
Alphabet (Google) Class C
GOOG
$2.58T
| $227K | 0.1% |
+2,560
| New | +$227K |
|
131
Walmart
WMT
$774B
| $227K | 0.1% |
+1,600
| New | +$227K |
|
132
PENN Entertainment
PENN
$2.95B
| $221K | 0.1% |
+7,455
| New | +$221K |
|
133
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $213K | 0.1% |
+880
| New | +$213K |
|
134
Crocs
CROX
$4.76B
| $208K | 0.09% |
+1,921
| New | +$208K |
|
135
Cadence Bank
CADE
$7.01B
| $201K | 0.09% |
+8,161
| New | +$201K |
|
136
Gold Fields
GFI
$30B
| $201K | 0.09% |
+19,382
| New | +$201K |
|
137
CarParts.com
PRTS
$45.3M
| $191K | 0.09% |
+30,463
| New | +$191K |
|
138
Tarsus Pharmaceuticals
TARS
$2.47B
| $190K | 0.09% |
+12,981
| New | +$190K |
|
139
Horizon Bancorp
HBNC
$864M
| $183K | 0.08% |
+12,114
| New | +$183K |
|
140
Beyond Air
XAIR
$11.6M
| $177K | 0.08% |
+27,337
| New | +$177K |
|
141
A10 Networks
ATEN
$1.28B
| $172K | 0.08% |
+10,360
| New | +$172K |
|
142
Aspen Aerogels
ASPN
$563M
| $169K | 0.08% |
+14,351
| New | +$169K |
|
143
Trevi Therapeutics
TRVI
$883M
| $169K | 0.08% |
+87,453
| New | +$169K |
|
144
Kura Oncology
KURA
$686M
| $166K | 0.08% |
+13,404
| New | +$166K |
|
145
Cytek Biosciences
CTKB
$527M
| $149K | 0.07% |
+14,565
| New | +$149K |
|
|
NVTA
146
DELISTED
Invitae Corporation
NVTA
| $116K | 0.05% |
+62,476
| New | +$116K |
|
147
Spok Holdings
SPOK
$374M
| $102K | 0.05% |
+12,473
| New | +$102K |
|
148
Eos Energy Enterprises
EOSE
$1.79B
| $97.5K | 0.04% |
+65,886
| New | +$97.5K |
|
149
Erasca
ERAS
$445M
| $96.4K | 0.04% |
+22,356
| New | +$96.4K |
|
150
Generation Bio
GBIO
$40.4M
| $78.9K | 0.04% |
+20,072
| New | +$78.9K |
|